Literature DB >> 16194459

Metastatic spinal cord compression.

Meic H Schmidt1, Paul Klimo, Frank D Vrionis.   

Abstract

Approximately 70% of cancer patients have metastatic disease at death. The spine is involved in up to 40% of those patients. Spinal cord compression may develop in 5% to 10% of cancer patients and up to 40% of patients with preexisting nonspinal bone metastasis (>25,000 cases/y). Given the increasing survival times of patients with cancer, greater numbers of patients are likely to develop this complication. The role of surgery in the management of metastatic spinal cord compression is expanding. The management of metastatic spine disease can consist of a combination of surgery, radiation treatment, and chemotherapy. Treatment modalities are not mutually exclusive and must be individualized for patients evaluated in a multidisciplinary setting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16194459     DOI: 10.6004/jnccn.2005.0041

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  8 in total

1.  Clinical outcomes of multileaf collimator-based CyberKnife for spine stereotactic body radiation therapy.

Authors:  Nalee Kim; Ho Lee; Jin Sung Kim; Jong Geal Baek; Chang Geol Lee; Sei Kyung Chang; Woong Sub Koom
Journal:  Br J Radiol       Date:  2017-09-04       Impact factor: 3.039

2.  The era of stereotactic body radiotherapy for spinal metastases and the multidisciplinary management of complex cases.

Authors:  Rachit Kumar; Anick Nater; Ahmed Hashmi; Sten Myrehaug; Young Lee; Lijun Ma; Kristin Redmond; Simon S Lo; Eric L Chang; Albert Yee; Charles G Fisher; Michael G Fehlings; Arjun Sahgal
Journal:  Neurooncol Pract       Date:  2015-07-27

3.  Multidisciplinary Approach to Patients With Metastatic Spinal Cord Compression: A Diagnostic Therapeutic Algorithm to Improve the Neurological Outcome.

Authors:  Rossella Rispoli; Chiara Reverberi; Giada Targato; Serena D'Agostini; Gianpiero Fasola; Marco Trovò; Mario Calci; Renato Fanin; Barbara Cappelletto
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

4.  Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical Trial.

Authors:  Peter J Hoskin; Kirsten Hopkins; Vivek Misra; Tanya Holt; Rhona McMenemin; Danny Dubois; Fiona McKinna; Bernadette Foran; Krishnaswamy Madhavan; Carol MacGregor; Andrew Bates; Noelle O'Rourke; Jason F Lester; Tim Sevitt; Daniel Roos; Sanjay Dixit; Gillian Brown; Seonaid Arnott; Sharon Shibu Thomas; Sharon Forsyth; Sandy Beare; Krystyna Reczko; Allan Hackshaw; Andre Lopes
Journal:  JAMA       Date:  2019-12-03       Impact factor: 56.272

5.  Metastatic spinal cord compression (MSCC) treated with palliative decompression: Surgical timing and survival rate.

Authors:  Wan-Yu Lo; Shu-Hua Yang
Journal:  PLoS One       Date:  2017-12-29       Impact factor: 3.240

6.  Preoperative Embolization of Spinal Metastatic Tumor: The Use of Selective Computed Tomography Angiography for the Detection of Radiculomedullary Arteries.

Authors:  Shohei Chatani; Shoichi Haimoto; Yozo Sato; Takaaki Hasegawa; Shinichi Murata; Hidekazu Yamaura; Yoshitaka Inaba
Journal:  Spine Surg Relat Res       Date:  2021-01-21

7.  The advantage of 3D conformal treatment of lumbar spine metastases in comparison to traditional PA or AP-PA techniques: restoring an intermediate niche of therapeutic sophistication.

Authors:  Viacheslav Soyfer; Benjamin W Corn; Natan Shtraus; Dan Schifter; Haim Tempelhof
Journal:  Radiat Oncol       Date:  2013-02-12       Impact factor: 3.481

8.  Conventionally-fractionated image-guided intensity modulated radiotherapy (IG-IMRT): a safe and effective treatment for cancer spinal metastasis.

Authors:  Youling Gong; Jin Wang; Sen Bai; Xiaoqin Jiang; Feng Xu
Journal:  Radiat Oncol       Date:  2008-04-22       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.